Dr Reddys Laboratories (RDY) Net Cash Flow (2009)
Dr Reddys Laboratories (RDY) posted quarterly Net Cash Flow of -$28.0 million for Q4 2009, down 240.0% quarter-over-quarter from $20.0 million in Q3 2009.
Dr Reddys Laboratories (RDY) Net Cash Flow (2009) Analysis & Trends
Dr Reddys Laboratories' Net Cash Flow history runs 1 years deep, the most recent figure standing at -$28.0 million for Q4 2009.
- In Q4 2009, Net Cash Flow changed N/A year-over-year to -$28.0 million; the TTM figure through Sep 2010 stood at -$28.0 million (down 324.18% YoY), while the FY2026 annual figure was -$5.0 million, down 105.88% from the prior year.
- Net Cash Flow for Q4 2009 stood at -$28.0 million, down from $20.0 million in the prior quarter.
- The five-year high for Net Cash Flow was $20.0 million in Q3 2009, with the low at -$28.0 million in Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 159.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2009 | -28.00 Mn |
| Dec 31, 2009 | -28.00 Mn |
| Sep 30, 2009 | 20.00 Mn |
| Sep 30, 2009 | 20.00 Mn |
| Jun 30, 2009 | 1.00 Mn |
| Jun 30, 2009 | 1.00 Mn |